关注
Jennifer Yu
Jennifer Yu
Department of Cardiology, Prince of Wales Hospital; Prince of Wales Clinical School, UNSW
在 health.nsw.gov.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Impact of the Everolimus-Eluting Stent on Stent ThrombosisA Meta-Analysis of 13 Randomized Trials
U Baber, R Mehran, SK Sharma, S Brar, J Yu, JW Suh, HS Kim, SJ Park, ...
Journal of the American College of Cardiology 58 (15), 1569-1577, 2011
3222011
Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy
A Narula, R Mehran, G Weisz, GD Dangas, J Yu, P Généreux, E Nikolsky, ...
European heart journal 35 (23), 1533-1540, 2014
2862014
High‐Intensity Interval Training for Patients With Cardiovascular Disease—Is It Safe? A Systematic Review
MA Wewege, D Ahn, J Yu, K Liou, A Keech
Journal of the American Heart Association 7 (21), e009305, 2018
2042018
Sex-based differences in outcomes with transcatheter aortic valve therapy: TVT registry from 2011 to 2014
J Chandrasekhar, G Dangas, J Yu, S Vemulapalli, S Suchindran, AN Vora, ...
Journal of the American College of Cardiology 68 (25), 2733-2744, 2016
1872016
Gut flora and bacterial translocation in chronic liver disease
J Almeida, S Galhenage, J Yu, J Kurtovic, SM Riordan
World journal of gastroenterology: WJG 12 (10), 1493, 2006
1742006
Sex‐based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: Three year results from the HORIZONS …
J Yu, R Mehran, L Grinfeld, K Xu, E Nikolsky, BR Brodie, B Witzenbichler, ...
Catheterization and Cardiovascular Interventions 85 (3), 359-368, 2015
1572015
Incidence and angiographic characteristics of patients With apical ballooning syndrome (takotsubo/stress cardiomyopathy) in the HORIZONS‐AMI trial: An analysis from a …
A Prasad, G Dangas, M Srinivasan, J Yu, BJ Gersh, R Mehran, GW Stone
Catheterization and Cardiovascular Interventions 83 (3), 343-348, 2014
1562014
Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial)
AI Larsen, DWT Nilsen, J Yu, R Mehran, E Nikolsky, AJ Lansky, A Caixeta, ...
The American journal of cardiology 111 (5), 643-648, 2013
1112013
New insights into the risk factors of contrast-induced encephalopathy
J Yu, G Dangas
J Endovasc Ther 18 (4), 545-6, 2011
862011
Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS …
RH Mehta, J Yu, JP Piccini, JE Tcheng, ME Farkouh, J Reiffel, M Fahy, ...
The American journal of cardiology 109 (6), 805-812, 2012
812012
Mobile Phone Technologies in the Management of Ischemic Heart Disease, Heart Failure, and Hypertension: Systematic Review and Meta-Analysis
P Indraratna, D Tardo, J Yu, K Delbaere, M Brodie, N Lovell, SY Ooi
JMIR mHealth and uHealth 8 (7), e16695, 2020
732020
Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing …
E Nikolsky, R Mehran, GD Dangas, J Yu, H Parise, K Xu, SJ Pocock, ...
The American journal of cardiology 109 (6), 831-838, 2012
732012
Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial.
P Tobbia, BR Brodie, B Witzenbichler, C Metzger, G Guagliumi, J Yu, ...
EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2013
702013
Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial
T Rakowski, D Dudek, A Dziewierz, J Yu, B Witzenbichler, G Guagliumi, ...
EuroIntervention 8 (11), 1307-1314, 2013
572013
B-type Natriuretic Peptide and Risk of Contrast-Induced Acute Kidney Injury in Acute ST-Segment–Elevation Myocardial Infarction: A Substudy from the HORIZONS-AMI Trial
R Jarai, G Dangas, K Huber, K Xu, BR Brodie, B Witzenbichler, ...
Circulation: Cardiovascular Interventions 5 (6), 813-820, 2012
562012
Sex-based differences in cessation of dual-antiplatelet therapy following percutaneous coronary intervention with stents
J Yu, U Baber, I Mastoris, G Dangas, S Sartori, PG Steg, DJ Cohen, ...
JACC: Cardiovascular Interventions 9 (14), 1461-1469, 2016
502016
Safety and Efficacy of High-Versus Low-Dose Aspirin After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial InfarctionThe HORIZONS-AMI (Harmonizing …
J Yu, R Mehran, GD Dangas, BE Claessen, U Baber, K Xu, H Parise, ...
JACC: Cardiovascular Interventions 5 (12), 1231-1238, 2012
452012
Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity
U Baber, J Bander, R Karajgikar, K Yadav, A Hadi, K Theodoropolous, ...
Thrombosis and haemostasis 110 (07), 118-123, 2013
422013
High-intensity interval training for patients with coronary artery disease: Finding the optimal balance
A Keech, K Holgate, J Fildes, P Indraratna, L Cummins, C Lewis, J Yu
International Journal of Cardiology, 2019
392019
Incidence and Impact of Totally Occluded Culprit Coronary Arteries in Patients Presenting With Non–ST-Segment Elevation Myocardial Infarction
J Warren, R Mehran, J Yu, K Xu, ME Bertrand, DA Cox, AM Lincoff, ...
The American journal of cardiology 115 (4), 428-433, 2015
382015
系统目前无法执行此操作,请稍后再试。
文章 1–20